These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16959877

  • 1. Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.
    Vlotides G, Cruz-Soto M, Rubinek T, Eigler T, Auernhammer CJ, Melmed S.
    Mol Endocrinol; 2006 Dec; 20(12):3321-35. PubMed ID: 16959877
    [Abstract] [Full Text] [Related]

  • 2. Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.
    Vlotides G, Zitzmann K, Hengge S, Engelhardt D, Stalla GK, Auernhammer CJ.
    Endocrinology; 2004 Feb; 145(2):716-27. PubMed ID: 14605001
    [Abstract] [Full Text] [Related]

  • 3. Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells.
    Tfelt-Hansen J, Yano S, Bandyopadhyay S, Carroll R, Brown EM, Chattopadhyay N.
    Endocrinology; 2004 Sep; 145(9):4222-31. PubMed ID: 15178645
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA, Gittoes NJ.
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [Abstract] [Full Text] [Related]

  • 5. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression.
    Wang Y, Li J, Ying Wang C, Yan Kwok AH, Leung FC.
    Endocrinology; 2007 Jul 27; 148(7):3426-40. PubMed ID: 17395697
    [Abstract] [Full Text] [Related]

  • 7. Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.
    Horwitz GA, Miklovsky I, Heaney AP, Ren SG, Melmed S.
    Mol Endocrinol; 2003 Apr 27; 17(4):600-9. PubMed ID: 12554778
    [Abstract] [Full Text] [Related]

  • 8. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M, Lule S, Demir O, Kurnaz IA, Vural I.
    Int J Biochem Cell Biol; 2012 Feb 27; 44(2):302-10. PubMed ID: 22085529
    [Abstract] [Full Text] [Related]

  • 9. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway.
    Kim DS, Franklyn JA, Boelaert K, Eggo MC, Watkinson JC, McCabe CJ.
    J Clin Endocrinol Metab; 2006 Nov 27; 91(11):4603-11. PubMed ID: 16926250
    [Abstract] [Full Text] [Related]

  • 10. Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.
    Vlotides G, Chen YH, Eigler T, Ren SG, Melmed S.
    Endocrinology; 2009 Jul 27; 150(7):3252-8. PubMed ID: 19359387
    [Abstract] [Full Text] [Related]

  • 11. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
    Li M, Wang J, Ng SS, Chan CY, He ML, Yu F, Lai L, Shi C, Chen Y, Yew DT, Kung HF, Lin MC.
    Cancer; 2009 Nov 01; 115(21):4959-72. PubMed ID: 19642173
    [Abstract] [Full Text] [Related]

  • 12. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
    Yan F, Hui YN, Li YJ, Guo CM, Meng H.
    Ophthalmologica; 2007 Dec 07; 221(4):244-50. PubMed ID: 17579290
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor stimulates proliferation and migration of porcine trophectoderm cells through protooncogenic protein kinase 1 and extracellular-signal-regulated kinases 1/2 mitogen-activated protein kinase signal transduction cascades during early pregnancy.
    Jeong W, Kim J, Bazer FW, Song G.
    Mol Cell Endocrinol; 2013 Dec 05; 381(1-2):302-11. PubMed ID: 24012778
    [Abstract] [Full Text] [Related]

  • 15. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
    Jiang L, Chen Y, Li Y, Lan T, Wu M, Wang Y, Qian H.
    Mol Med Rep; 2014 Apr 05; 9(4):1405-9. PubMed ID: 24534906
    [Abstract] [Full Text] [Related]

  • 16. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
    Mahimainathan L, Ghosh-Choudhury N, Venkatesan BA, Danda RS, Choudhury GG.
    Am J Physiol Renal Physiol; 2005 Jul 05; 289(1):F72-82. PubMed ID: 15701816
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY, Lee SW, Hong JP, Chang SE, Choe H, Choi J.
    Cancer Lett; 2009 Oct 08; 283(2):135-42. PubMed ID: 19380191
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 19. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 20. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 01; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.